Diane M. Cappelletty
-
- Antibiotic Use and Resistance 5
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 8
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy 11
- Clinical Biochemistry top 5%
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility 3
- Antimicrobial Resistance in Staphylococcus 2
-
- Pneumonia and Respiratory Infections 9
- Fungal Infections and Studies 2
-
- Pharmaceutical studies and practices 2
- Co-authors
- Michael J. RybakJames A. KruseSangrim KangGlenn W. KaatzShirley PalmerJeffrey R. AeschlimannRaymond YostRichard L. Slaughter
- Journals
- Antimicrobial Agents and Chemotherapy (7 papers)The Pediatric Infectious Disease Journal (1 paper)International Journal of Antimicrobial Agents (1 paper)
- Partner nations
- United States
In The Last Decade
Diane M. Cappelletty
21 papers receiving 876 citations
Peers
Comparison fields: 5 of 94
- Applied Microbiology and Biotechnology 161
- Molecular Medicine 338
- Pharmacology 466
- Clinical Biochemistry 133
- Infectious Diseases 352
Countries citing papers authored by Diane M. Cappelletty
This map shows the geographic impact of Diane M. Cappelletty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane M. Cappelletty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane M. Cappelletty more than expected).
Fields of papers citing papers by Diane M. Cappelletty
This network shows the impact of papers produced by Diane M. Cappelletty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane M. Cappelletty. The network helps show where Diane M. Cappelletty may publish in the future.
Co-authorship network
The 17 scholars most cited alongside Diane M. Cappelletty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 31 | |
| 2 | 2013 | 27 | |
| 3 | 2011 | 70 | |
| 4 | 2010 | 2 | |
| 5 | 2009 | 4 | |
| 6 | 2009 | 1 | |
| 7 | 2007 | 156 | |
| 8 | 2007 | 5 | |
| 9 | 2006 | 1 | |
| 10 | 2000 | 12 | |
| 11 | 1999 | 6 | |
| 12 | 1999 | 11 | |
| 13 | 1998 | 63 | |
| 14 | 1998 | 32 | |
| 15 | 1998 | 128 | |
| 16 | 1997 | 1 | |
| 17 | 1996 | 104 | |
| 18 | 1996 | 16 | |
| 19 | 1996 | 133 | |
| 20 | 1995 | 48 |
About Diane M. Cappelletty
Diane M. Cappelletty is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Pharmacology, having authored 21 papers that have together received 908 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (11 papers), Pneumonia and Respiratory Infections (9 papers), Antibiotic Resistance in Bacteria (8 papers), Antibiotic Use and Resistance (5 papers), Antifungal resistance and susceptibility (3 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Fungal Infections and Studies (2 papers) and Pharmaceutical studies and practices (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (161 citations), Molecular Medicine (338 citations) and Pharmacology (466 citations). Diane M. Cappelletty has collaborated with scholars based in United States. Frequent co-authors include Michael J. Rybak, James A. Kruse, Sangrim Kang, Glenn W. Kaatz, Shirley Palmer, Jeffrey R. Aeschlimann, Raymond Yost, Richard L. Slaughter, David M. Jacobs and Rose Jung. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, The Pediatric Infectious Disease Journal and International Journal of Antimicrobial Agents.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.